Antoine F Carpentier

6PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 01, 2023
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.

Patrick R Benusiglio, Fikret Elder, Mehdi Touat

|Dec 11, 2022
Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy.

Stefania Cuzzubbo, Benoit Roch, Guillaume Darrasse-Jèze

|Feb 18, 2021
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM).

Thomas Cluzeau, Marie Sebert, Ramy Rahmé

|Sep 19, 2020
Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases.

Pauline Tétu, Lila Sirven-Villaros, Stefania Cuzzubbo

|Jul 18, 2017
Synthetic melanin bound to subunit vaccine antigens significantly enhances CD8+ T-cell responses.

Antoine F Carpentier, Frédéric Geinguenaud, Thi Tran

Pageof 1